Engineered anti-CD20 antibodies with enhanced complement-activating capacity mediate potent anti-lymphoma activity (Q43275812)
scientific article published on 25 August 2009
Language:
(P31) (Q13442814)
(P304) 2411-2418
(P407) (Q1860)
(P433) 12
(P478) 100
(P577) Tuesday, August 25, 2009
(P921) (Q79460)
(P1433) (Q326125)
(P1476) "Engineered anti-CD20 antibodies with enhanced complement-activating capacity mediate potent anti-lymphoma activity" (language: en)
(P2093) Akito Natsume
Yukiko Shimizu-Yokoyama
Mitsuo Satoh
Kenya Shitara
Rinpei Niwa
(P2860) (Q47745204)
(Q30312115)
(Q31839167)
(Q40259623)
(Q30835165)
other details
description scientific article published on 25 August 2009

External Links